Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01832766Phase 2Terminated
Phase 2, randomised, double-blind trial in schizophrenia comparing Dronabinol First with Placebo First (2 arms). Primary endpoint: P50 Auditory Evoked Potential. Started Jun 2005; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01832766.